Chief Medical Officer Dr. Allyson Gage Interviewed by Applied Clinical Trials

Hear from CVB's Chief Medical Officer about the benefits of adaptive platform trial design.

In a recent interview with Applied Clinical Trials, our Chief Medical Officer Dr. Allyson Gage discussed the benefits of adaptive platform trial design, especially for diseases where the underlying biology and mechanism of disease is undetermined.

Read the article “What You Need to Know About Adaptive Platform Design” to learn more.

Share this article:

More from CVB

Cohen Veterans Network Publishes White Paper Providing Recommendations for Measurement-Based Mental Health Care

Cohen Veterans Bioscience Joins Veteran Matthew Mitchell on Military Makeover with Montel to Discuss Traumatic Brain Injury

Cohen Veterans Bioscience and 22 Jumps Announce Parachuting with Purpose: Recognizing the Epidemic of Veterans Suicide as a Result of Traumatic Brain Injury (TBI) and PTSD

About Cohen Veterans Bioscience (CVB)

Cohen Veterans Bioscience is a non-profit 501(c)(3) biomedical research and technology organization dedicated to advancing brain health by fast-tracking precision diagnostics and tailored therapeutics.